A weight-loss cell phone app alone did not help overweight young adults sustain weight loss any better than a written handout did.
Used alone, an app-based approach to weight loss was of only limited use for overweight young adults, according to new research from investigators at Duke Medicine and published online in Obesity.
The randomized study included 365 people ages 18 to 35 years who were overweight or obese. One group of participants used an Android app called CITY (Cell Phone Intervention for You) that was designed exclusively for the study. It tracked calorie intake, activity, and weight loss goals and also offered weight loss tips and opportunities to connect with other users of the app for social support. A second group received written 3-page handouts promoting healthy eating and more exercise (controls), and a third group received personal coaching enhanced by smartphone self-monitoring. The coaches met with participants weekly for 6 weeks and then followed up with monthly phone meetings.
Participants who had the personal coaching intervention lost a mean of 1.92 kg more than controls at 6 months (P = .003) but not at 12 or 24 months. After 2 years there was no sign that either using a phone app or a personal coach was any more effective than getting a handout about weight loss at the doctor’s office.
This study was the longest and largest trial investigating the use of cell phone apps to modify eating and exercise behavior, according to the study’s lead author Laura P. Svetkey, MD, professor of medicine at the Duke University School of Medicine. She said that while the app did work for some people, on average the difference between results with the app and in the control group was insignificant.
“It doesn’t mean that cell phone apps can’t work for weight control, but this one didn’t,” she concluded. “We thought that because this is an age group that is most engaged in technology, it might be possible to intervene and prevent future problems like cardiovascular disease, high blood pressure, and diabetes while they are still developing their lifestyle habits.”
Study coauthor Gary G. Bennett, PhD, Bishop-MacDermott Family Professor of Psychology and Neuroscience at Duke, said researchers need to continue to develop tools for young adults, including apps. Research has focused on older people, a missed opportunity because young adults are having a hard time losing weight and keeping it off, and need interventions to offset health risks later on.
“A lot of people can lose weight in a short amount of time,” he said. “The real question is, can they keep it off in the long term.”
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
June 6th 2025Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More